Cargando…
Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
After more than a decade of preclinical and clinical development, therapeutic infusion of mesenchymal stromal cells is now a leading investigational strategy for the treatment of acute graft-versus-host disease (GVHD). While their clinical use continues to expand, it is still unknown which of their...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618297/ https://www.ncbi.nlm.nih.gov/pubmed/28671556 http://dx.doi.org/10.3390/biomedicines5030039 |
_version_ | 1783267154482692096 |
---|---|
author | Dunavin, Neil Dias, Ajoy Li, Meizhang McGuirk, Joseph |
author_facet | Dunavin, Neil Dias, Ajoy Li, Meizhang McGuirk, Joseph |
author_sort | Dunavin, Neil |
collection | PubMed |
description | After more than a decade of preclinical and clinical development, therapeutic infusion of mesenchymal stromal cells is now a leading investigational strategy for the treatment of acute graft-versus-host disease (GVHD). While their clinical use continues to expand, it is still unknown which of their immunomodulatory properties contributes most to their therapeutic activity. Herein we describe the proposed mechanisms, focusing on the inhibitory activity of mesenchymal stromal cells (MSCs) at immunologic checkpoints. A deeper understanding of the mechanism of action will allow us to design more effective treatment strategies. |
format | Online Article Text |
id | pubmed-5618297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56182972017-09-29 Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease? Dunavin, Neil Dias, Ajoy Li, Meizhang McGuirk, Joseph Biomedicines Review After more than a decade of preclinical and clinical development, therapeutic infusion of mesenchymal stromal cells is now a leading investigational strategy for the treatment of acute graft-versus-host disease (GVHD). While their clinical use continues to expand, it is still unknown which of their immunomodulatory properties contributes most to their therapeutic activity. Herein we describe the proposed mechanisms, focusing on the inhibitory activity of mesenchymal stromal cells (MSCs) at immunologic checkpoints. A deeper understanding of the mechanism of action will allow us to design more effective treatment strategies. MDPI 2017-07-01 /pmc/articles/PMC5618297/ /pubmed/28671556 http://dx.doi.org/10.3390/biomedicines5030039 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Dunavin, Neil Dias, Ajoy Li, Meizhang McGuirk, Joseph Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease? |
title | Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease? |
title_full | Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease? |
title_fullStr | Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease? |
title_full_unstemmed | Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease? |
title_short | Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease? |
title_sort | mesenchymal stromal cells: what is the mechanism in acute graft-versus-host disease? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618297/ https://www.ncbi.nlm.nih.gov/pubmed/28671556 http://dx.doi.org/10.3390/biomedicines5030039 |
work_keys_str_mv | AT dunavinneil mesenchymalstromalcellswhatisthemechanisminacutegraftversushostdisease AT diasajoy mesenchymalstromalcellswhatisthemechanisminacutegraftversushostdisease AT limeizhang mesenchymalstromalcellswhatisthemechanisminacutegraftversushostdisease AT mcguirkjoseph mesenchymalstromalcellswhatisthemechanisminacutegraftversushostdisease |